How One Conference Plans to Improve STEM Participation

The 2019-2020 academic year is in full swing, but a significant industry event will take place before schools pause for winter break.

The National Science Teaching Association (NSTA) Conference of Science Education is scheduled for December 12-14 at the Washington State Convention Center in Seattle, Wash.

Delivering the keynote address is Nalini M. Nadkarni, a professor in the Department of Biology and STEMAP Director at the University of Utah. The speech will take place on Thursday, Dec. 12 at 9:15 a.m. PT.

Professional development is a staple of any quality industry event, and this year’s conference will focus on three distinct strands for educators to pursue.

Providing STEM Pathways for the Future

Being a science organization’s conference, the emphasis in this strand is on broadening science opportunities for students from the beginning of their academic careers. Educators will learn through this strand how to better provide such opportunities for their pupils, even those just entering pre-K.

Building Partnerships for Effective Science Education

Collaboration is important in and profession and this skill starts in the classroom. This strand will help participants realize the importance of a team-oriented learning environment. In the science field, these partnerships are particularly important, but relationships with peers in other fields also spur growth in and out of the classroom or work world.

Finding Joy in Experiencing Science

Simply put, to encourage more participation in science and STEM fields, students must enjoy it. Opportunities to participate in science projects and courses is imperative to this enjoyment, but through this strand educators will become familiar with ways to engage in the science field and how to promote STEM learning.

Also at this year’s event is an opportunity to earn one or two graduate-level credits in professional development. Dominican University of California will credit the course #9039. More details can be found on the event’s website here.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More